StockData
Bluejay Diagnostics, Inc. logo

Bluejay Diagnostics, Inc. (BJDX) stock

BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$1.83−0.32 (-15.08%)

Close on Nov 18, 2026Market cap $8.18MP/E –Yield –

Bluejay Diagnostics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Bluejay Diagnostics

Bluejay Diagnostics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Bluejay Diagnostics figures

See a number that looks wrong?